What were the key takeaways from Unilever's earnings call?

Did Unilever beat or miss consensus estimates last quarter?

What is Unilever's gross profit margin?

What is the revenue and EPS growth rate for Unilever year over year?

What does Unilever do and what are its main business segments?

What is Unilever's latest dividend and current dividend yield?

What factors drove the changes in Unilever's revenue and profit?

What guidance did Unilever's management provide for the next earnings period?

- **Revenue Resilience**: 3.5% underlying growth in 2025, driven by North America (5.3%) and emerging markets (India +5%, Indonesia +17% Q4).
- **Gross Margin Expansion**: 46.9% gross margin, up 20 bps, supported by procurement savings and mix shift.
- **Strategic Acquisitions**: €1.5 billion buyback announced, with €670 million of €800 million productivity program delivered.
- **2026 Outlook**: 4-6% sales growth, modest margin expansion, and focus on Beauty & Wellbeing (16% of turnover).

**【CEO Summary Section】**
- **Revenue Growth**: Underlying sales grew 3.5% in 2025, driven by volume (1.5%) and price (2%). North America delivered 5.3% growth, outperforming the market.
- **Portfolio Reshaping**: 15% of the portfolio was rotated, with acquisitions like Minimalist, Wild, and Dr. Squatch, and exits of non-core assets (e.g., Unilever Russia, China water purification).
- **Emerging Markets**: India, Indonesia, and Latin America saw sequential improvement, with India achieving 5% Q4 growth and Indonesia returning to double-digit growth after corrective pricing actions.
- **Strategic Focus**: Increased investment in Beauty & Wellbeing (16% of turnover) and sharpened focus on premium segments and e-commerce.

**【CFO Financial Commentary】**
- **Gross Margin Expansion**: Gross margin improved 20 basis points to 46.9%, driven by mix, procurement savings, and commodity hedging.
- **Productivity Savings**: Delivered €670 million of the €800 million productivity program, with 50% of CapEx allocated to margin-enhancing initiatives.
- **Free Cash Flow**: €5.9 billion (100% conversion), supporting €6 billion in shareholder returns (€4.5 billion dividends, €1.5 billion buybacks).
- **2026 Outlook**: Guided for 4-6% underlying sales growth, with modest margin expansion and €1.5 billion buyback.

**【Q&A Highlights】**
- **Emerging Markets**: Brazil Deodorants to rebalance aerosol vs. contact applicator formats; Indonesia reset with low distributor stock and brand relaunches.
- **U.S. Performance**: Wellbeing growth moderating in Q4 due to channel assortment issues, but Dove Hair and Vaseline maintain strong momentum.
- **Innovation Pipeline**: 2026 launches include UV repair Dove, Nexxus in China, and FIFA World Cup activations.
- **Pricing Strategy**: 2026 inflation expected to be lower, with focus on selective pricing to offset wage and commodity costs.
- **Productivity**: Cultural shift to keep overheads <2% of turnover, with 50% of incremental BMI behind Power Brands.

Unilever PLC (UL) Q4 2025 Earnings Call Transcript

- **Strong First Half Growth**: 3.4% underlying sales growth with broad-based volume gains, outperforming in North America (+5.4%) and Europe (+3.4%).
- **Emerging Market Recovery**: Asia (+3.5% H1, +5% Q2), India (+5% Q2), and China/Indonesia showing sequential improvement; Latin America faces challenges but maintains competitive share.
- **Ice Cream Demerger**: Business operating standalone since July; Unilever retains 20% stake for up to 5 years, with proceeds offsetting separation costs.
- **H2 Outlook**: Accelerated growth in emerging markets, 18.5%+ operating margin target, and no compromise on brand investment (~15-16% of turnover).
- **Productivity & Cash Flow**: €650M productivity savings (€100M above guidance), free cash flow conversion ~100%, and M&A focused on premium, digitally-native brands.


**【CEO Summary Section】**
- **Resilient First Half Performance**: Underlying sales growth of 3.4% (3.8% in Q2), driven by balanced volume and price growth. Volume growth was broad-based across all business groups, with North America (+5.4%) and Europe (+3.4%) outperforming.
- **Emerging Market Progress**: Asia Pacific Africa (+3.5% H1, +5% Q2), India (+5% Q2), and China/Indonesia showing sequential improvements. Latin America faced challenges due to currency-driven price increases and slowing markets, but Unilever maintained competitive share gains.
- **Ice Cream Demerger Update**: The business began operating standalone in July, with a Capital Markets Day scheduled for September. Unilever will retain a 20% stake for up to 5 years, with proceeds used to offset separation costs and reduce debt.
- **Second Half Outlook**: Expect accelerated growth in emerging markets (Asia, India) and sustained momentum in developed markets. Underlying operating margin for H2 is targeted at least 18.5%, up 100+ bps vs. H2 2024.

**【CFO Financial Commentary】**
- **Topline Growth**: Q2 underlying sales +3.8% (vs. +3.4% H1), with 1.8% volume and 2% price. Developed markets (+4.3% H1) and Ice Cream (+5.9% H1) led performance. Power Brands (e.g., Vaseline, Liquid IV) grew 4.4% Q2, outpacing the group.
- **Margin Dynamics**: Underlying operating margin 19.3% (down 30 bps vs. prior year), driven by 15.5% brand investment. Gross margin improvements offset inflation, with productivity savings of €650M (€100M above guidance). Free cash flow €1.1B H1, with full-year conversion target of ~100%.
- **Currency Impact**: €5-6% negative impact on full-year turnover, primarily from euro-dollar dynamics. Tax rate expected ~26% for the year.
- **M&A Activity**: Acquired Wild (UK refillable deodorant), Dr. Squatch (US male grooming), and Minimalist (India premium beauty), aligning with premium, digitally-native brand strategy.

**【Q&A Highlights】**
- **Emerging Markets**: India's Q2 growth (+5%) driven by premium innovations and e-commerce expansion. Indonesia and China showing sequential improvement, with China close to flat in Q2. Latin America's Q2 volume decline (-6%) due to pricing actions and macro weakness, but share gains sustained.
- **US Performance**: Beauty & Wellbeing and Personal Care >75% of US business post-Ice Cream demerger. Dove, Nutrafol, and Liquid IV leading growth. US Foods (Hellmann's, Knorr) delivered 100 bps margin improvement via pricing, mix, and productivity.
- **Margin Guidance**: H2 operating margin >18.5% (vs. 17.1% H2 2024), driven by volume leverage, productivity, and gross margin expansion. No compromise on brand investment (~15-16% of turnover).
- **Ice Cream Spin-Off**: Retained stake to support transition, with proceeds used for debt reduction. Ice Cream's standalone EBITDA target of ~2.4x net debt, positioning for long-term value creation.


Actual														0
Forecast														1.7539
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-100.00%

Actual	--	--	--	--	--	--	--	--	--	--	--	--	--	29.65B
Forecast	--	--	--	--	--	--	--	--	--	--	--	--	--	31.39B
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-5.57%

UL

UL fundamentals

UL Q4 2025 Earnings

Earnings Call

You can ask Aime

UL

UL fundamentals

UL Q4 2025 Earnings

Earnings Call

UL Earnings Call Summary for Q4/20254:00 AM on Feb 12, 2026

UL Earnings Call Summary for Q2/20253:00 AM on Jul 31, 2025

UL Earnings Call Summary for Q4/2024 Mar 25, 2026

UL Earnings Call Summary for Q2/2024 Mar 25, 2026

UL Earnings Call Summary for Q4/20233:00 AM on Feb 8, 2024

You can ask Aime